Skip to main content
Pharma Equity Group A/S logo

Pharma Equity Group A/S — Investor Relations & Filings

Ticker · BLVIS ISIN · DK0061155009 LEI · 2138008SUI4D917FKN20 CO Financial and insurance activities
Open in API
Filings indexed 1,627 across all filing types
Latest filing 2012-08-15 Interim / Quarterly Rep…
Country DK Denmark
Listing CO BLVIS

About Pharma Equity Group A/S

https://bcbsfepvision.com/

Pharma Equity Group A/S is an investment company specializing in early-stage biotechnology, life science, and MedTech companies. The group's mission is to support its portfolio companies in developing novel therapies and effective medicines for unmet medical needs. A primary investment is its subsidiary, Reponex Pharmaceuticals, a clinical-stage biopharmaceutical company focused on developing treatments for serious, acute, and chronic inflammatory diseases. The company is actively expanding its portfolio through strategic acquisitions to support its growth.

Recent filings

Filing Released Lang Actions
Interim / Quarterly Report 2012
Interim / Quarterly Report Classification · 100% confidence The document title 'Delårsrapport 1.januar – 30 juni 2012' translates from Danish to 'Interim Report 1 January – 30 June 2012'. This indicates a comprehensive financial report for a period shorter than a full fiscal year, which fits the definition of an Interim/Quarterly Report (IR). H1 2012
2012-08-15 Danish
Capital/Financing Update 2012
Capital/Financing Update Classification · 95% confidence The document is a short official announcement (Årets meddelelse nr.: 9) dated July 6, 2012, detailing an amendment to a prior agreement regarding the payment terms (Tranche 2) for a property purchase. It discusses specific monetary amounts, dates of payment modification, and interest rates. This content relates to a change in financing or capital structure obligations, specifically concerning a debt repayment schedule modification. This fits best under 'Capital/Financing Update' (CAP), as it directly alters the terms of a significant financial obligation/transaction. It is too specific for a general 'Regulatory Filing' (RNS) and does not fit any other category like earnings, management changes, or shareholder votes.
2012-07-06 Danish
Capital/Financing Update 2012
Capital/Financing Update Classification · 99% confidence The document is a short announcement dated July 6, 2012, from Blue Vision A/S regarding an amendment to a payment agreement for a property purchase with Freja Ejendomme A/S. It details changes to the payment schedule (Tranche 2) and interest rates. This type of specific, material corporate event announcement, which is not a full financial report (10-K, IR), earnings release (ER), or dividend notice (DIV), fits best under the general category for regulatory announcements that don't have a more specific code. Since it announces a material change in financing/payment terms, it could potentially be CAP (Capital/Financing Update), but given its nature as a formal, brief notification of a specific transaction detail, and the lack of a dedicated 'Material Event Disclosure' code, the most appropriate general regulatory filing category is RNS (Regulatory Filings), as it is a formal company announcement that doesn't fit the other specific financial reporting codes.
2012-07-06 English
Share Issue/Capital Change 2012
Share Issue/Capital Change Classification · 99% confidence The document is a short company announcement ("SELSKABSMEDDELELSE") dated May 31, 2012, titled "Udsættelse af fortegningsemission" (Postponement of rights issue). It explicitly discusses the delay of a planned rights issue (a financing activity) intended to strengthen liquidity and refinance debt. This directly relates to capital structure changes and fundraising activities. Based on the definitions, 'Capital/Financing Update' (CAP) is the most appropriate classification, as it details a change in the timing of a planned capital raise. The document is short and is an announcement about a financing event, not the final prospectus itself.
2012-05-31 English
Share Issue/Capital Change 2012
Share Issue/Capital Change Classification · 99% confidence The document is a short company announcement (1101 characters) dated May 31, 2012, from Blue Vision A/S. It discusses the postponement ('Udsættelse') of a rights issue ('fortegningsemission') originally planned for Q2 2012, stating the new expectation is the second half of 2012. This directly relates to fundraising, financing activities, and capital structure changes. This aligns perfectly with the definition for Capital/Financing Update (CAP). It is not a full report, so RPA or RNS are less specific.
2012-05-31 Danish
AGM Information 2012
AGM Information Classification · 99% confidence The document text details the proceedings of a general meeting, including the election of a chairman (dirigent), the presentation and approval of the audited annual report ('årsrapport'), granting discharge to the board and management, approving the distribution of profit/loss, amending bylaws, and electing board members and auditors. The structure and content explicitly describe the agenda and resolutions passed at an Annual General Meeting (AGM). This aligns perfectly with the definition for AGM Information (AGM-R). Although the Annual Report (10-K) is mentioned for approval, the document itself is the record of the meeting, not the full annual report.
2012-04-30 Danish

Browse filings by year

20 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.